id
related bits
0
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2024-08-11 18:13:37
expired found date
-
created at
2024-08-11 18:13:37
updated at
2026-03-04 10:57:04
length
17
crc
58936
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
51401364 (ars-pharma.com)
previous id
0
replaced with id
0
related id
-
dns primary id
0
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
1
count cert errors
0
count timeouts
6
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
2026-03-06 14:57:04
server bits
—
server ip
mp import status
20
mp rejected date
-
mp saved date
2025-11-12 00:21:59
mp size orig
48831
mp size raw text
2276
mp inner links count
4
mp inner links status
20 (imported)
title
Investors - ARS Pharmaceuticals
description
The Investor Relations website contains information about ARS Pharmaceuticals's business for stockholders, potential investors, and financial analysts.
image
site name
ARS Pharmaceuticals
author
updated
2026-02-14 07:13:16
raw text
Investors - ARS Pharmaceuticals Skip to main navigation - ARS Pharma - Investor Relations About Us Meet Our Team Careers Job Openings Product neffy neffy 2mg neffyConnect Prescribing information Pipeline Investors & Media Events & Presentations Press Releases Stock Information Stock Quote & Chart Analyst Coverage Financials & Filings SEC Filings Corporate Governance Documents & Charters Board of Directors Management Team Committee Composition Compliance Program IR Resources Email Alerts Stay Connected Scientific Presentations Stay Connected Community Program neffyinSchools Contact Us Investors & Media Corporate Profile ARS Pharmaceuticals is dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The Company is developing neffy ™ (ARS-1), an intranasal epinephrine product in clinical development for patients and...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
Economy [en] (222)
index version
2025123101
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
1738
text words
282
text unique words
165
text lines
69
text sentences
9
text paragraphs
4
text words per sentence
31
text matched phrases
1
text matched dictionaries
3
links self subdomains
0
links other subdomains
0
links other domains
20 - ars-pharma.com
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
0
links ext klim
0
links ext generic
0
dol status
0
dol updated
2026-02-14 07:13:16
rss path
rss status
0 (new)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
0 (new)
sitemap review version
2
sitemap urls count
0
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
-
sitemap process date
-
sitemap first import date
-
sitemap last import date
-